Company Inotek Pharmaceuticals Corp Nasdaq
Equities
US45780V1026
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- | - |
05-10 | UBS Adjusts Rocket Pharmaceuticals Price Target to $51 From $54, Maintains Buy Rating | MT |
05-10 | Rocket Pharmaceuticals Says Blood Disorder Therapies Show Promise | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 03/01/18 |
Kinnari Patel
PSD | President | 46 | 03/01/18 |
Chief Tech/Sci/R&D Officer | 60 | 31/12/15 | |
Mayo Pujols
CTO | Chief Tech/Sci/R&D Officer | 55 | 26/07/22 |
David Southwell
BRD | Director/Board Member | 63 | 31/07/14 |
Brooks Rahmer
IRC | Investor Relations Contact | - | - |
Mark White
PRN | Corporate Officer/Principal | 57 | 03/04/23 |
Carlos Martin
PRN | Corporate Officer/Principal | - | - |
Isabel Carmona
HRO | Human Resources Officer | - | 06/09/21 |
Gayatri R. Rao
PRN | Corporate Officer/Principal | - | 30/04/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Pedro Granadillo
BRD | Director/Board Member | 77 | 03/01/18 |
Carsten Boess
BRD | Director/Board Member | 57 | 31/12/15 |
David Southwell
BRD | Director/Board Member | 63 | 31/07/14 |
Rod Wong
CHM | Chairman | 47 | 31/12/17 |
Director/Board Member | 47 | 31/12/17 | |
Gotham Makker
BRD | Director/Board Member | 50 | 03/01/18 |
Fady Malik
BRD | Director/Board Member | 59 | 09/03/22 |
Director/Board Member | 63 | 19/04/20 | |
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 03/01/18 |
R. Woods
BRD | Director/Board Member | 57 | 12-11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 90,782,211 | 85,963,246 ( 94.69 %) | 0 | 94.69 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+5.66% | 111B | |
+11.23% | 105B | |
-1.75% | 21.93B | |
-12.15% | 22.34B | |
-6.22% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- RCKT Stock
- Stock
- Company Inotek Pharmaceuticals Corp